150 related articles for article (PubMed ID: 31980187)
1. [Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review].
Maillet F; Pineton De Chambrun M; Monzani Q; Mercy G; Schuffenecker I; Mirand A; Deback C; Charlotte F; Fourniols E; Mathian A; Amoura Z
Rev Med Interne; 2020 Mar; 41(3):200-205. PubMed ID: 31980187
[TBL] [Abstract][Full Text] [Related]
2. Clinical, neuropathological and radiological evidence for a rare complication of rituximab therapy.
Healy EG; Phadke R; Kidd M; Reilly MM; Lunn MP
Neuromuscul Disord; 2015 Jul; 25(7):589-92. PubMed ID: 25958339
[TBL] [Abstract][Full Text] [Related]
3. Antiviral treatment with fluoxetine for rituximab-associated chronic echovirus 13 meningoencephalitis and myofasciitis.
Vermeersch G; Laenen L; Lens G; van der Elst KCM; Thal DR; Jentjens S; Demaerel P; Van Nieuwenhuyse T; Wollants E; Boeckx N; Verhaert N; Dubois B; Kuppeveld FJM; Woei-A-Jin FJSH
Eur J Neurol; 2022 Oct; 29(10):3117-3123. PubMed ID: 35763378
[TBL] [Abstract][Full Text] [Related]
4. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
Schilthuizen C; Berenschot HW; Levin MD
Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
[TBL] [Abstract][Full Text] [Related]
5. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
Toubi E
Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
Deshayes S; Khellaf M; Zarour A; Layese R; Fain O; Terriou L; Viallard JF; Cheze S; Graveleau J; Slama B; Audia S; Cliquennois M; Ebbo M; Le Guenno G; Salles G; Bonmati C; Teillet F; Galicier L; Lambotte O; Hot A; Lefrère F; Mahévas M; Canoui-Poitrine F; Michel M; Godeau B
Am J Hematol; 2019 Dec; 94(12):1314-1324. PubMed ID: 31489694
[TBL] [Abstract][Full Text] [Related]
7. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
McAtee CL; Lubega J; Underbrink K; Curry K; Msaouel P; Barrow M; Muscal E; Lotze T; Srivaths P; Forbes LR; Allen C; Bernhardt MB
JAMA Netw Open; 2021 Feb; 4(2):e2036321. PubMed ID: 33533931
[TBL] [Abstract][Full Text] [Related]
8. [Rituximab and hypogammaglobulinemia].
Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
[TBL] [Abstract][Full Text] [Related]
9. Viral panniculitis in a patient with disseminated opportunistic Enterovirus infection.
Tekin B; Boire N; Shah K; Hanson J; Bridges AG
J Cutan Pathol; 2021 Mar; 48(3):434-438. PubMed ID: 33277938
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.
Mease PJ; Ochs HD; Wedgwood RJ
N Engl J Med; 1981 May; 304(21):1278-81. PubMed ID: 6783908
[No Abstract] [Full Text] [Related]
11. Immunoglobulin-induced aseptic meningitis: a case report.
Graça L; Alves J; Nuak J; Sarmento A
BMC Neurol; 2018 Jul; 18(1):97. PubMed ID: 30016937
[TBL] [Abstract][Full Text] [Related]
12. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
13. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B
Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241
[TBL] [Abstract][Full Text] [Related]
14. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.
Grisariu S; Vaxman I; Gatt M; Elias S; Avni B; Arad A; Pasvolsky O; Raanani P; Paltiel O
Hematol Oncol; 2017 Dec; 35(4):591-598. PubMed ID: 27734521
[TBL] [Abstract][Full Text] [Related]
15. A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid.
Alborizi A; Hosseini-nasab A; Zeyaeian M; Sanaei A; Kashef S
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):117-9. PubMed ID: 19671942
[TBL] [Abstract][Full Text] [Related]
16. Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.
Shaheen N; Mussai F
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e27-e29. PubMed ID: 29315142
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
Khojah AM; Miller ML; Klein-Gitelman MS; Curran ML; Hans V; Pachman LM; Fuleihan RL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):61. PubMed ID: 31462263
[TBL] [Abstract][Full Text] [Related]
18. Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.
Wildenbeest JG; van den Broek PJ; Benschop KS; Koen G; Wierenga PC; Vossen AC; Kuijpers TW; Wolthers KC
Antivir Ther; 2012; 17(3):459-66. PubMed ID: 22293148
[TBL] [Abstract][Full Text] [Related]
19. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
[TBL] [Abstract][Full Text] [Related]
20. Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?
Barmettler S; Price C
J Allergy Clin Immunol; 2015 Nov; 136(5):1407-9. PubMed ID: 26277594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
